Acute Porphyria Drug Database

V03AC02 - Deferiprone
Propably not porphyrinogenic
PNP

Rationale
Non-CYP metabolism.
Chemical description
(To be edited, initial data ST OCT 04) Bidentate ligand which binds iron. Used for treatment of iron excess in thalassemia, and in cases where deferoxamine has given rise to toxic reactions. Excreted in unchanged form, as glucuronide and as iron-ferioprone complex.

Similar drugs
Explore alternative drugs in similar therapeutic classes V03A / V03AC or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙